Credo Health Buys Affineon, Renames Itself Pajama.ai for Doctors
Credo Health bought Affineon Health and now operates as Pajama.ai, an AI tool for doctors' charts, labs and refills. Price and terms were not disclosed.

Denver-based Credo Health has bought Affineon Health and taken the name Pajama.ai, the company announced Nov. 16 through PR Newswire. Its software gets patient charts ready ahead of appointments and deals with lab results and refill requests. No price or other terms were disclosed.
The company claims the merged product returns about 40 hours a month to each doctor by absorbing work that otherwise spills into evenings. That work happens in the electronic health record (EHR), the system clinics use to store patient files.
The problem behind the name
“Pajama time” is the company’s label for after-hours paperwork: looking over tomorrow’s charts, approving lab results and signing off on refills. The announcement points to 2026 federal data showing that one in three family physicians put in three or more hours of documentation each day outside normal hours.
Each half of the deal covers a different step. Credo’s technology collects a patient’s records into one history and then looks for undiagnosed conditions, gaps in care, medication problems, overdue screenings and worrying trends. Affineon’s system takes action once results arrive. It can finish chart prep, email a patient whose tests came back normal and weed out a duplicate refill request.
Size and early results
Pajama.ai says the combined business serves more than 200 clinical groups, 3,000 doctors and 5 million patients. It runs inside the EHR tools practices already have and is priced as a monthly subscription.
The company says the product handles 40% to 60% of inbox messages automatically and saves three to five minutes of chart preparation for every patient. These numbers come from the company itself, not from an outside review.
The announcement quotes two users. Leslie Chiang, DO, of Peachtree Medical Center, uses the chart prep feature and said its insights often alter her handling of a case immediately. Mia M. Painter, chief operating officer at San Marcos Family Medicine and an Affineon customer, reported over a 50% drop in inbox volume.
Leadership after the deal
Carm Huntress, who co-founded the company, remains chief executive. Before this, he founded Arrive Health, which according to the announcement delivered real-time prescription drug pricing to 600,000 providers across the country. Evan Grossman, until now Affineon’s chief executive, becomes chief product officer and will direct the joint product plans. The announcement says he spent nine years at athenahealth and has held roles at Zus Health, Innovaccer and CodeMetrix.
Grossman said Affineon’s current customers will keep the same tools. The addition for them is that practices already using the inbox automation can now get chart prep as well.
Why it matters
Clinics that used one vendor for pre-visit preparation and another for follow-up work can now buy both from a single company. Affineon customers were told to expect no change to what they use today. Because the price and deal structure were withheld, there are no figures on what Credo paid or how ownership was divided.
What to watch next
Pajama.ai plans to show the product at HLTH 2026, held Nov. 15 to 18 at The Venetian Expo in Las Vegas.
Source: PR Newswire



